首页> 美国卫生研究院文献>other >Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: Conversion to resection and long-term outcomes

【2h】

Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: Conversion to resection and long-term outcomes

机译：肝动脉输注和全身化疗对结直肠癌无法切除的肝转移患者的II期试验：转换为切除术和长期预后

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeEvaluate conversion rate of patients with unresectable colorectal-liver metastasis to complete resection with hepatic-arterial infusion plus systemic chemotherapy including bevacizumab.

机译：目的评估无法切除的结直肠肝转移患者的肝动脉输液加全身化疗（包括贝伐单抗）的完全切除率。

著录项

期刊名称 other
作者
Michael I. D’Angelica; Camilo Correa-Gallego; Philip B. Paty; Andrea Cercek; Alexandra N. Gewirtz; Joanne F. Chou; Marinella Capanu; T. Peter Kingham; Yuman Fong; Ronald P. DeMatteo; Peter J. Allen; William R. Jarnagin; Nancy Kemeny;
展开▼
作者单位

展开▼
年(卷),期 -1(261),2
年度 -1
页码 353–360
总页数 19
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer Conversion to Resection and Long-term Outcomes [J] . DAngelica Michael I., Correa-Gallego Camilo, Paty Philip B., Annals of Surgery . 2015,第2期

机译：从结肠直肠癌转换为切除和长期结局的无法切除的肝转移患者的肝动脉灌注和全身化学治疗的II期试验
2. Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure [J] . Yozo Sato, Yoshitaka Inaba, Takashi Ura, Journal of gastrointestinal cancer. . 2018,第2期

机译：奥沙利铂肝动脉输注的I / II试验结果结合静脉化5-氟尿嘧啶和L-Leucovorin与全身化疗衰竭后结直肠癌的不可切入性肝转移患者的患者
3. Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution [J] . Ammori John B., Kemeny Nancy E., Fong Yuman, Annals of surgical oncology . 2013,第9期

机译：在无法切除的结直肠癌肝转移患者中，采用肝动脉灌注化疗转换为完全切除和/或消融术：在单一机构中的十年经验
4. Clinical Trial of Liposome-Adriamycin (Lipo-ADR) via the Portal Vein and Hepatic Artery for Prophylaxis and Treatment after Hepatic Resection on Liver Metastasis in Advanced Gastric Cancer [C] . I. Mizuno, T. Yotsuyanagi, M. Ishida, International Gastric Cancer Congress . 2009

机译：脂质体 - 亚霉素（Lipo-ADR）通过门静脉和肝动脉进行预防和治疗治疗晚期胃癌肝转移后的临床试验
5. Transcriptional and transductional adenovirus targeting therapy for hepatic colorectal cancer metastases. [D] . Li, Hua-Jung. 2007

机译：转录和转导腺病毒靶向治疗肝大肠癌转移。
6. Prospective Phase II Trial of Combination Hepatic Artery Infusion and Systemic Chemotherapy For Unresectable Colorectal Liver Metastases: Long Term Results and Curative Potential [O] . Linda M. Pak, Nancy E. Kemeny, Marinela Capanu, -1

机译：肝动脉输注与全身化疗联合治疗无法切除的结直肠肝转移的前瞻性II期试验：长期结果和治疗潜力
7. Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer [O] . Nancy E. Kemeny, William R. Jarnagin, Marinela Capanu, 2011

机译：辅助肝动脉输注的随机期II试验和患者患者中患者的肝脏肝动脉输注和系统化疗，从结肠直肠癌切除肝脏转移患者

Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: Conversion to resection and long-term outcomes

摘要

著录项

相似文献

相关主题

期刊订阅